Knight Therapeutics | GUD - 股本和储备

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD 0.13

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 943.92M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	股本和储备	更改		日
Acasti Pharma	USD 64.89M		2.07M	2025-12
Akebia Therapeutics	USD 27.38M		5.24M	2026-03
Alaunos Therapeutics	USD 1.29M		865K	2026-03
Aurora Cannabis	CAD 536.36M		30.74M	2025-12
Avita Medical	AUD -16.65M		3.76M	2025-12
Canopy Growth	CAD 758.17M		22.16M	2025-12
Cronos Group	USD 1.07B		20.24M	2026-03
Dianthus Therapeutics	USD 1.2B		707.91M	2026-03
Ionis Pharmaceuticals	USD 491.41M		2.32M	2026-03
IQVIA Holdings	USD 6.22B		282M	2026-03
Knight Therapeutics	CAD 767.27M		480K	2025-12
Moderna	USD 7.41B		1.24B	2026-03
Omeros	USD -228.68M		15.13M	2025-06
Organigram Holdings	CAD 369.46M		20.33M	2025-12
Organon & Co	USD 903M		151M	2026-03
Revvity	USD 7.25B		125.54M	2025-12
Tectonic Therapeutic	USD 230.42M		20.91M	2026-03
Tilray	USD 1.58B		39.08M	2025-09
Viatris	USD 14.66B		53.6M	2026-03
Xeris Pharmaceuticals	USD 13.01M		678K	2026-03